| |
|
|
|
|
|
|
|||
|
Blood, 8 October 2009, Vol. 114, No. 15, pp. 3325-3328. Prepublished online as a Blood First Edition Paper on May 29, 2009; DOI 10.1182/blood-2008-04-149047.
PLATELETS AND THROMBOPOIESIS The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity1 Department of Medical Oncology and Immunology, Graduate School of Medical Sciences, Nagoya City University, Nagoya; 2 Higashi Municipal Hospital of Nagoya City University, Nagoya; and 3 Department of Internal Medicine, Division of Hematology, Aichi Medical University, Aichi, Japan We previously reported that a dominant-positive activating mutation (Asn505) in the transmembrane domain (TMD) of c-MPL, which encodes the thrombopoietin receptor, caused familial essential thrombocythemia. Here, we show that the Asn505 mutation induces both autonomous dimerization of c-Mpl and signal activation in the absence of its ligand. Signal activation was preserved in a truncated mutant of Asn505 that lacked the extracellular domain of c-MPL. We also found that the substitution of the amino acid (AA) residue at position 505 with others of strong polarity (Glu, Asp, or Gln) also resulted in activated dimerization without ligand stimulation. Overall, these data show that the Asn505 mutation transduced the signal through the autonomous dimerization of the c-MPL protein due to strong AA polarity. This finding provides a new insight into the mechanism of disease causation by mutations in the TMD of cytokine/hematopoietic receptors.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||